These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12016245)

  • 1. Truths about the NINDS study: setting the record straight.
    Mann J
    West J Med; 2002 May; 176(3):192-4. PubMed ID: 12016245
    [No Abstract]   [Full Text] [Related]  

  • 2. Thrombolysis for acute ischemic stroke: still a treatment for the few by the few.
    Wardlaw JM; Lindley RI; Lewis S
    West J Med; 2002 May; 176(3):198-9. PubMed ID: 12016247
    [No Abstract]   [Full Text] [Related]  

  • 3. NINDS Reanalysis Committee's reanalysis of the NINDS trial.
    Mann J
    Stroke; 2005 Feb; 36(2):230-1; author reply 230-1. PubMed ID: 15637327
    [No Abstract]   [Full Text] [Related]  

  • 4. Stroking the data: re-analysis of the NINDS trial.
    Magid D; Naviaux N; Wears RL
    Ann Emerg Med; 2005 Apr; 45(4):385-7. PubMed ID: 15795716
    [No Abstract]   [Full Text] [Related]  

  • 5. Emergency physician survey: recombinant tissue plasminogen activator for stroke.
    Mann J
    Ann Emerg Med; 2006 Oct; 48(4):476; author reply 477. PubMed ID: 16997689
    [No Abstract]   [Full Text] [Related]  

  • 6. Alteplase for ischaemic stroke--much sooner is much better.
    Saver JL; Levine SR
    Lancet; 2010 May; 375(9727):1667-8. PubMed ID: 20472152
    [No Abstract]   [Full Text] [Related]  

  • 7. When is enough enough?
    Donnan GA; Davis SM
    Stroke; 2001 Nov; 32(11):2710-1. PubMed ID: 11692042
    [No Abstract]   [Full Text] [Related]  

  • 8. Further randomized controlled trials of tissue plasminogen activator within 3 hours are required.
    Lindley RI
    Stroke; 2001 Nov; 32(11):2708-9. PubMed ID: 11692040
    [No Abstract]   [Full Text] [Related]  

  • 9. Reasons for exclusion from thrombolytic therapy following acute ischemic stroke.
    Schestatsky P; Picon PD
    Neurology; 2005 Dec; 65(11):1844; author reply 1844. PubMed ID: 16344546
    [No Abstract]   [Full Text] [Related]  

  • 10. [Intravenous thrombolysis in the treatment of acute ischaemic stroke: 3, 4.5, or 6 hours?].
    Kwieciński H
    Neurol Neurochir Pol; 2009; 43(3):213-5. PubMed ID: 19618303
    [No Abstract]   [Full Text] [Related]  

  • 11. 4.5 hours: the new time window for tissue plasminogen activator in stroke.
    Davis SM; Donnan GA
    Stroke; 2009 Jun; 40(6):2266-7. PubMed ID: 19407232
    [No Abstract]   [Full Text] [Related]  

  • 12. Questions about authorisation of alteplase for ischaemic stroke.
    Shinton R
    Lancet; 2014 Aug; 384(9944):659-60. PubMed ID: 25152265
    [No Abstract]   [Full Text] [Related]  

  • 13. Reasons for exclusion from thrombolytic therapy following acute ischemic stroke.
    Kleindorfer DO; Khatri P; Katzan I
    Neurology; 2005 Dec; 65(11):1844; author reply 1844. PubMed ID: 16353320
    [No Abstract]   [Full Text] [Related]  

  • 14. Findings from the reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial.
    Ingall TJ; O'Fallon WM; Asplund K; Goldfrank LR; Hertzberg VS; Louis TA; Christianson TJ
    Stroke; 2004 Oct; 35(10):2418-24. PubMed ID: 15345796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NXY-059 for acute ischemic stroke: the promise of neuroprotection is finally realized?
    Fisher M
    Stroke; 2006 Oct; 37(10):2651-2. PubMed ID: 16946143
    [No Abstract]   [Full Text] [Related]  

  • 16. A hundred (and one) graphs tell only part of the story.
    Silbergleit R
    Ann Emerg Med; 2009 Sep; 54(3):342-3. PubMed ID: 19695418
    [No Abstract]   [Full Text] [Related]  

  • 17. Further randomized controlled trials of tPA within 3 hours are required-not!
    Lyden PD
    Stroke; 2001 Nov; 32(11):2709-10. PubMed ID: 11692041
    [No Abstract]   [Full Text] [Related]  

  • 18. A graphic reanalysis of the NINDS Trial.
    Hoffman JR; Schriger DL
    Ann Emerg Med; 2009 Sep; 54(3):329-36, 336.e1-35. PubMed ID: 19464756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The stroke care revolution.
    Lancet Neurol; 2015 Apr; 14(4):341. PubMed ID: 25752414
    [No Abstract]   [Full Text] [Related]  

  • 20. tPA for acute stroke: balancing baseline imbalances.
    Mann J
    CMAJ; 2002 Jun; 166(13):1651-2; author reply 1652-3. PubMed ID: 12126317
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.